Literature DB >> 23740024

Preliminary observations and clinical value of lipid peak in high-grade uterine sarcomas using in vivo proton MR spectroscopy.

Mayumi Takeuchi1, Kenji Matsuzaki, Masafumi Harada.   

Abstract

OBJECTIVE: To retrospectively evaluate the clinical significance of the lipid peak in in vivo proton magnetic resonance spectroscopy (MRS) for the diagnosis of high-grade uterine sarcomas.
METHODS: MRS was performed in patients with 38 pathologically diagnosed uterine corpus tumours (26 leiomyomas and 12 sarcomas) at 3 T. Single-voxel MRS data were collected from a single square volume of interest that encompassed the tumours. The concentrations of lipid and total choline compounds (tCho) were classified as high, low or none.
RESULTS: High lipid peaks were observed in all 12 sarcomas and not in benign leiomyomas except for 1 lipoleiomyoma. All 26 leiomyomas and 10 of the 12 sarcomas showed tCho peaks, whereas 2 sarcomas with massive necrosis showed no tCho peak. The presence of a high lipid peak for the diagnosis of sarcoma had a sensitivity of 100 %, specificity of 96 %, positive predictive value of 92 % and negative predictive value of 100 %.
CONCLUSIONS: The high lipid peaks in high-grade malignant tumours may be observed in both viable and necrotic areas, and may be useful in distinguishing uterine sarcomas from benign leiomyomas. KEY POINTS: • High lipid peak on MR spectroscopy is suggestive of uterine sarcomas. • Lipid peak is observed in both viable and necrotic areas in sarcomas. • MR spectroscopy may be useful in distinguishing uterine sarcomas from benign leiomyomas.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740024     DOI: 10.1007/s00330-013-2856-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  22 in total

Review 1.  MR-visible lipids and the tumor microenvironment.

Authors:  E James Delikatny; Sanjeev Chawla; Daniel-Joseph Leung; Harish Poptani
Journal:  NMR Biomed       Date:  2011-04-27       Impact factor: 4.044

Review 2.  Molecular imaging of cancer: MR spectroscopy and beyond.

Authors:  K Pinker; A Stadlbauer; W Bogner; S Gruber; T H Helbich
Journal:  Eur J Radiol       Date:  2010-06-04       Impact factor: 3.528

Review 3.  Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds.

Authors:  H Ueda; K Togashi; I Konishi; M L Kataoka; T Koyama; T Fujiwara; H Kobayashi; S Fujii; J Konishi
Journal:  Radiographics       Date:  1999-10       Impact factor: 5.333

4.  Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging.

Authors:  M Rijpkema; J Schuuring; Y van der Meulen; M van der Graaf; H Bernsen; R Boerman; A van der Kogel; A Heerschap
Journal:  NMR Biomed       Date:  2003-02       Impact factor: 4.044

5.  Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging.

Authors:  Mayumi Takeuchi; Kenji Matsuzaki; Hiromu Nishitani
Journal:  J Comput Assist Tomogr       Date:  2009 Nov-Dec       Impact factor: 1.826

6.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

7.  Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions.

Authors:  E J Delikatny; P Russell; J C Hunter; R Hancock; K H Atkinson; C van Haaften-Day; C E Mountford
Journal:  Radiology       Date:  1993-09       Impact factor: 11.105

8.  Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis.

Authors:  H Poptani; R K Gupta; V K Jain; R Roy; R Pandey
Journal:  Magn Reson Imaging       Date:  1995       Impact factor: 2.546

9.  (1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumor load.

Authors:  Marrita M Mahon; I Jane Cox; Roberto Dina; W Patrick Soutter; G Angus McIndoe; Andreanna D Williams; Nandita M deSouza
Journal:  J Magn Reson Imaging       Date:  2004-03       Impact factor: 4.813

10.  Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms.

Authors:  H Hricak; D Tscholakoff; L Heinrichs; M R Fisher; G C Dooms; C Reinhold; R B Jaffe
Journal:  Radiology       Date:  1986-02       Impact factor: 11.105

View more
  7 in total

1.  MR Spectra of Normal Adult Testes and Variations with Age: Preliminary Observations.

Authors:  Athina C Tsili; Loukas G Astrakas; Alexandra Ntorkou; Dimitrios Giannakis; Sotirios Stavrou; Vasilios Maliakas; Nikolaos Sofikitis; Maria I Argyropoulou
Journal:  Eur Radiol       Date:  2015-10-16       Impact factor: 5.315

Review 2.  Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?

Authors:  Roberto García-Figueiras; Sandra Baleato-González; Anwar R Padhani; Laura Oleaga; Joan C Vilanova; Antonio Luna; Juan Carlos Cobas Gómez
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

Review 3.  Advances in the Preoperative Identification of Uterine Sarcoma.

Authors:  Junxiu Liu; Zijie Wang
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

4.  In vivo biochemical investigation of spermatogenic status: 1H-MR spectroscopy of testes with nonobstructive azoospermia.

Authors:  Alexandra Ntorkou; Athina C Tsili; Loukas Astrakas; Anna Goussia; Eleni Panopoulou; Nikolaos Sofikitis; Maria I Argyropoulou
Journal:  Eur Radiol       Date:  2020-03-30       Impact factor: 5.315

5.  Potential biomarker for human uterine leiomyosarcoma.

Authors:  Takuma Hayashi; Akiko Horiuchi; Hiroyuki Aburatani; Osamu Ishiko; Nobuo Yaegashi; Yae Kanai; Dorit Zharhary; Tanri Shiozawa; Susumu Tonegawa; Ikuo Konishi
Journal:  J Clin Med Res       Date:  2014-07-28

6.  Imaging Findings From Different Pathological Types of Oral and Maxillofacial Intramuscular Hemangiomas for Selecting Optimum Management.

Authors:  Dan Zhu; Xiaoqing Dai; Jingbo Wang; Chunye Zhang; Xiaofeng Tao; Lizhong Wu; Ling Zhu
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

7.  Incidence and clinical characteristics of unexpected uterine sarcoma after hysterectomy and myomectomy for uterine fibroids: a retrospective study of 10,248 cases.

Authors:  Wan-Cheng Zhao; Fang-Fang Bi; Da Li; Qing Yang
Journal:  Onco Targets Ther       Date:  2015-10-15       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.